LI
NVO

LHM Inc’s Novo Nordisk NVO Stock Holding History

LHM Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
25,105
-34,825
-58% -$1.5M 0.41% 23
2026
Q1 		$2.25M Sell
59,930
-81,557
-58% -$3.86M 0.89% 21
2025
Q4 		$7.2M Hold
141,487
– – 2.68% 12
2025
Q3 		$7.85M Hold
141,487
– – 2.6% 13
2025
Q2 		$9.77M Buy
141,487
+3,036
+2% +$207K 3.24% 7
2025
Q1 		$9.73M Buy
+138,451
New +$11.4M 3.22% 5

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LHM Inc's NVO Position: Q2 2026 in Review

LHM Inc reduced its Novo Nordisk (NVO) stake by 58% in Q2 2026, selling an estimated $1.5M and leaving 25,105 shares worth $1.2M. The position accounts for 0.41% of the portfolio, ranked #23.

LHM Inc first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.77M in Q2 2025. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • LHM Inc held 25,105 shares of Novo Nordisk worth $1.2M as of Q2 2026.
  • LHM Inc sold 34,825 Novo Nordisk shares in Q2 2026, an estimated $1.5M.
  • Novo Nordisk made up 0.41% of LHM Inc's portfolio in Q2 2026, its #23 holding.
  • LHM Inc first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • LHM Inc's Novo Nordisk position peaked at $9.77M in Q2 2025.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on LHM Inc's 13F filing for Q2 2026, filed 12 Aug 2026.